SEC Filing Details
Document Details
Form
Filing Date
Mar 26, 2024
Document Date
Mar 22, 2024
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
ARS Pharmaceuticals
Issuer
ARS PHARMACEUTICALS, INC.
Filer
Lowenthal Richard E